-
EU Drug Watchdog Wants Avelox Use Limited Mainly Due To Liver Toxicity Concerns
Risk Of Adverse Hepatic Reactions, Including Fatal Liver Injury, Is Cited by European Regulators At July 2008 Meeting (Posted by Tom Lamb at DrugInjuryWatch.com) The Committee for Medicinal Products for Human Use (CHMP), a…
-
Neurology Journal: Johnson & Johnson’s Drug Topamax May Increase Risk of Birth Defects
Beware If Taking This Seizure Medicine Alone Or With Other Epilepsy Drugs During Pregnancy (Posted by Tom Lamb at DrugInjuryWatch.com) The July 22, 2008 issue of Neurology, the medical journal of the American Academy…
-
The FDA Is Not Ready For Federal Preemption Of Lawsuits Involving Drugs And Medical Devices
Something Old And Something New: Two Items From July 3, 2008 NEJM Show Why Preemption Applied In These Types Of Cases Is Bad Public Policy (Posted by Tom Lamb at DrugInjuryWatch.com) We start with…
-
FDA Needs To Assure Us That There Is Quality Control For Generic Medications Sold In U.S.
In Wake of “Double-Dose” Digitek Pills And ETHEX Morphine Tablets Being Recalled, Drugmaker Ranbaxy Faces Allegations About Fake Data As Regards Quality Of Its Generic Drugs (Posted by Tom Lamb at DrugInjuryWatch.com) A July 15,…
-
Will There Be An Avelox – Liver Toxicity Warning Letter From Bayer Coming Soon In The U.S., Or Not?
In July 2008 FDA Said Avelox, With Other Antibiotics In Fluoroquinolone Class, Would Add A “Black-Box” Warning For Tendinitis And Tendon Ruptures (Posted by Tom Lamb at DrugInjuryWatch.com) On July 8, 2008 the FDA…